After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
ACLS belongs to the Technology sector of the NASDAQ while operating in the Semiconductor Equipment & Materials industry. The current market capitalization of Axcelis Technologies Inc is $3.32B. A total of 0.55 million shares were traded on the day, compared to an average of 676.69K shares.
In the most recent transaction, Low Russell bought 440 shares of ACLS for 112.39 per share on Mar 11 ’24. After the transaction, the PRESIDENT AND CEO now owns 57,754 company shares. In a previous transaction on Feb 29 ’24, COOGAN JAMES GORDON bought 100 shares at 112.23 per share. ACLS shares that EVP AND CFO owns now total 5,991.
Among the insiders who bought shares, Lawson Douglas A. acquired of 500 shares on Feb 23 ’24 at a per-share price of $111.04. This resulted in the EVP, CORPORATE MKTG & STRATEGY holding 19,648 shares of ACLS after the transaction. In another insider transaction, KEITHLEY JOSEPH P sold 500 shares at $140.50 per share on Dec 14 ’23. Company shares held by the Director now total 3,157.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ACLS has a high of $201.00 and a low of $102.36.
As of this writing, ACLS has an earnings estimate of $Axcelis Technologies, Inc. per share for the current quarter. EPS was calculated based on a consensus of Apellis Pharmaceuticals, Inc. estimates, with a high estimate of $Arcellx, Inc. per share and a lower estimate of $Celestica, Inc..
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ACLS’s latest balance sheet shows that the firm has $294.92M in Cash & Short Term Investments as of fiscal 2021. There were $47.39M in debt and $150.14M in liabilities at the time. Its Book Value Per Share was $26.46, while its Total Shareholder’s Equity was $538.96M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACLS is Buy with a score of 4.14.
